Back to trial detailsIntake questionnaire
Ovarian Cancer Liquid Biopsy for Early Assessment & Detection in Individuals With BRCA1/2 Pathogenic Variants
Applying to Weill Cornell Medicine · New York, New York
Answer a few short questions to share with the research team.
0 of 4 answered